Afficher la couverture 'Pulmonary hypertension reported with immune checkpoint inhibitors: a pharmacovigilance study | Palassin, Pascale' en grand format
/5

0 avis

Pulmonary hypertension reported with immune checkpoint inhibitors: a pharmacovigilance study

Archive ouverte

Palassin, Pascale | Maria, Alexandre | Ladhari, Chayma | Quantin, Xavier | Montani, David | Bourdin, Arnaud | Boissin, Clément | Fesler, Pierre | Hillaire-Buys, Dominique | Guilpain, Philippe | Faillie, Jean-Luc

Edité par CCSD ; Springer Verlag -

International audience. Immune checkpoint inhibitors (ICI) restore immune response against cancer cells that can lead to immune-related adverse effects. While cardiovascular immune-related adverse effects are known to be associated with checkpoint inhibitors, recent case reports have raised concerns about the potential association with pulmonary hypertension (PH). By using the global pharmacovigilance database VigiBase, we investigated the onset of PH associated with ICI and propose a comprehensive description of the 42 cases of PH reported with ICI recorded in this database. Through this study and review of the cases published in the literature, we discuss the possible link between PH and ICI in the context of cancer in order to better understand this rare but potentially fatal event

Suggestions

Du même auteur

Rheumatic disorders associated with immune checkpoint inhibitors: what about myositis? An analysis of the WHO's adverse drug reactions database.

Archive ouverte | Nguyễn, Thủy | CCSD

International audience. As shown by Kostine et al,1 and recently underlined by Ceccarelli et al,2 rheumatic inflammatory disorders induced by anticancer therapy are becoming a major concern for rheumatologists at th...

Cholangitis Induced by Immune Checkpoint Inhibitors: Analysis of Pharmacovigilance Data

Archive ouverte | Meunier, Lucy | CCSD

International audience. Immune checkpoint inhibitors (ICIs) are remarkable anticancer therapies that have revolutionized the oncological prognosis of many cancers.1 The considerable efficacy of ICIs is associated wi...

Immune checkpoint inhibitors induced liver injury: an observational study

Archive ouverte | Hountondji, Lina | CCSD

International audience. Introduction: Liver toxicity associated with immune checkpoint inhibitors (ICI), such as PD-1, PD-L1 and CTLA-4 inhibitors, is frequent. International guidelines recommend pausing immunothera...

Chargement des enrichissements...